Skip to main content
SpringerLink
Log in
Book cover

Neurolaryngology pp 99–107Cite as

Spasmodic Dysphonia (Laryngeal Dystonia)

  • Chapter
  • First Online:

  • 950 Accesses

Abstract

Spasmodic dysphonia (SD) or laryngeal dystonia is a focal voice disorder that produces involuntary spasms of the vocal folds, resulting in a strained-strangled voice production. Symptoms of SD come in several varieties. The disorder can be broadly divided into three forms: adductor-type SD, abductor-type SD, and mixed-type SD. The most common adductor-type causes a tight, “strangled-sounding” voice quality, often with abrupt starting and stopping of the voice. The abductor-type causes a breathy, whispering voice. Most cases of SD are primary and develop in adults (adult-onset). There is no cure for SD, and little is known on risk factors that contribute to its development. The diagnosis is mainly based on speech analysis. Injecting botulinum toxin has become the treatment of choice for 30 years. However, the disorder typically remains chronic after onset, and repeated injections therefore are needed.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   149.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Van Pelt F, Ludlow CL, Smith PJ. Comparison of muscle activation patterns in adductor and abductor spasmodic dysphonia. Ann Otol Rhinol Laryngol. 1994;103:192–200.

    Article  PubMed  Google Scholar 

  2. Biller HF, Som ML, Lawson W. Laryngeal nerve crush for spastic dysphonia. Ann Otol Rhinol Laryngol. 1983;92:469.

    Article  CAS  PubMed  Google Scholar 

  3. Schweinfurth JM, Billante M, Courey MS. Risk factors and demographics in patients with spasmodic dysphonia. Laryngoscope. 2002;112:220–3.

    Article  PubMed  Google Scholar 

  4. Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ III. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord. 1988;3:188–94.

    Article  CAS  PubMed  Google Scholar 

  5. Butler AG, Duffey PO, Hawthorne MR, Barnes MP. An epidemiologic survey of dystonia within the entire population of northeast England over the past nine years. Adv Neurol. 2004;94:95–9.

    PubMed  Google Scholar 

  6. Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope. 1998;108:1435–41.

    Article  CAS  PubMed  Google Scholar 

  7. Marras C, Lohmann K, Lang A, Klein C. Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples. Neurology. 2012;78:1016–24.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Tanner K, Roy N, Merrill RM, et al. Risk and protective factors for spasmodic dysphonia: a case-control investigation. J Voice. 2011;25:e35–46.

    Article  PubMed  Google Scholar 

  9. Perlmutter JS, Mink JW. Dysfunction of dopaminergic pathways in dystonia. Adv Neurol. 2004;94:163–70.

    PubMed  Google Scholar 

  10. Cohen LG, Ludlow CL, Warden M, et al. Blink reflex excitability recovery curves in patients with spasmodic dysphonia. Neurology. 1989;39:572–7.

    Article  CAS  PubMed  Google Scholar 

  11. Simonyan K, Ludlow CL. Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study. Cereb Cortex. 2010;20:2749–59.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Childs L, Rickert S, Murry T, Blitzer A, Sulica L. Patient perceptions of factors leading to spasmodic dysphonia: a combined clinical experience of 350 patients. Laryngoscope. 2011;121:2195–8.

    Article  PubMed  Google Scholar 

  13. Sataloff RT, Mandel S, Mann EA, Ludlow CL. Practice parameter: laryngeal electromyography (an evidence-based review). Otolaryngol Head Neck Surg. 2004;130:770–9.

    Article  PubMed  Google Scholar 

  14. Van Houtte E, Claeys S, D'Haeseleer E, Wuyts F, Van Lierde K. An examination of surface EMG for the assessment of muscle tension dysphonia. J Voice. 2013;27:177–86.

    Article  PubMed  Google Scholar 

  15. Yang Q, Xu W, Li Y, Cheng L. Value of laryngeal electromyography in spasmodic dysphonia diagnosis and therapy. Ann Otol Rhinol Laryngol. 2015;124(7):579–83.

    Article  PubMed  Google Scholar 

  16. Watts C, Nye C, Whurr R. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review. Clin Rehabil. 2006;20:112–22.

    Article  PubMed  Google Scholar 

  17. Watts CR, Truong DD, Nye C. Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs. J Neural Transm. 2008;115:625–30.

    Article  CAS  PubMed  Google Scholar 

  18. Simpson DM, Blitzer A, Brashear A, et al. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70:1699–706.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Bielamowicz S, Squire S, Bidus K, Ludlow CL. Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia. Ann Otol Rhinol Laryngol. 2001;110:406–12.

    Article  CAS  PubMed  Google Scholar 

  20. Garcia Ruiz PJ, Cenjor Espanol C, Sanchez Bernardos V, Astarloa R, Sanabria J, Garcia de Yebenes J. Botulinum toxin treatment for spasmodic dysphonia: percutaneous versus transoral approach. Clin Neuropharmacol. 1998;21:196–8.

    CAS  PubMed  Google Scholar 

  21. Kim JW, Park JH, Park KN, Lee SW. Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: a prospective comparative study. Sci World J. 2014;2014:327928.

    Google Scholar 

  22. Stong BC, DelGaudio JM, Hapner ER, Johns MM III. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia. Arch Otolaryngol Head Neck Surg. 2005;131:793–5.

    Article  PubMed  Google Scholar 

  23. Holden PK, Vokes DE, Taylor MB, Till JA, Crumley RL. Long-term botulinum toxin dose consistency for treatment of adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol. 2007;116:891–6.

    Article  PubMed  Google Scholar 

  24. Holzer SE, Ludlow CL. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia. Laryngoscope. 1996;106:86–92.

    Article  CAS  PubMed  Google Scholar 

  25. Novakovic D, Waters HH, D'Elia JB, Blitzer A. Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes. Laryngoscope. 2011;121:606–12.

    Article  CAS  PubMed  Google Scholar 

  26. Venkatesan NN, Johns MM, Hapner ER, DelGaudio JM. Abductor paralysis after botox injection for adductor spasmodic dysphonia. Laryngoscope. 2010;120:1177–80.

    PubMed  Google Scholar 

  27. Nakamura K, Muta H, Watanabe Y, Mochizuki R, Yoshida T, Suzuki M. Surgical treatment for adductor spasmodic dysphonia–efficacy of bilateral thyroarytenoid myectomy under microlaryngoscopy. Acta Otolaryngol. 2008;128:1348–53.

    Article  PubMed  Google Scholar 

  28. Tsuji DH, Takahashi MT, Imamura R, Hachiya A, Sennes LU. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality. J Voice. 2012;26:666 e7–12.

    Article  Google Scholar 

  29. Su CY, Lai CC, Wu PY, Huang HH. Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome. Laryngoscope. 2010;120:313–8.

    PubMed  Google Scholar 

  30. Koufman JA, Rees CJ, Halum SL, Blalock D. Treatment of adductor-type spasmodic dysphonia by surgical myectomy: a preliminary report. Ann Otol Rhinol Laryngol. 2006;115:97–102.

    Article  PubMed  Google Scholar 

  31. Gandhi S, Remacle M, Mishra P, Desai V. Vocal outcome after endoscopic thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia. Eur Arch Otorhinolaryngol. 2014;271:3249–54.

    Article  PubMed  Google Scholar 

  32. Isshiki N, Haji T, Yamamoto Y, Mahieu HF. Thyroplasty for adductor spasmodic dysphonia: further experiences. Laryngoscope. 2001;111:615–21.

    Article  CAS  PubMed  Google Scholar 

  33. Sanuki T, Isshiki N. Overall evaluation of effectiveness of type II thyroplasty for adductor spasmodic dysphonia. Laryngoscope. 2007;117:2255–9.

    Article  PubMed  Google Scholar 

  34. Chan SW, Baxter M, Oates J, Yorston A. Long-term results of type II thyroplasty for adductor spasmodic dysphonia. Laryngoscope. 2004;114:1604–8.

    Article  PubMed  Google Scholar 

  35. Nomoto M, Tokashiki R, Hiramatsu H, et al. The comparison of thyroarytenoid muscle myectomy and type II thyroplasty for spasmodic dysphonia. J Voice. 2015;29(4):501–6.

    Article  PubMed  Google Scholar 

  36. Dedo HH. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol. 1976;85:451–9.

    Article  CAS  PubMed  Google Scholar 

  37. Berke GS, Blackwell KE, Gerratt BR, Verneil A, Jackson KS, Sercarz JA. Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol. 1999;108:227–31.

    Article  CAS  PubMed  Google Scholar 

  38. Allegretto M, Morrison M, Rammage L, Lau DP. Selective denervation: reinnervation for the control of adductor spasmodic dysphonia. J Otolaryngol. 2003;32:185–9.

    Article  PubMed  Google Scholar 

  39. Chhetri DK, Mendelsohn AH, Blumin JH, Berke GS. Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia. Laryngoscope. 2006;116:635–42.

    Article  PubMed  Google Scholar 

  40. Mendelsohn AH, Berke GS. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study. Ann Otol Rhinol Laryngol. 2012;121:231–8.

    Article  PubMed  Google Scholar 

  41. Willinger U, Volkl-Kernstock S, Aschauer HN. Marked depression and anxiety in patients with functional dysphonia. Psychiatry Res. 2005;134:85–91.

    Article  PubMed  Google Scholar 

  42. Silverman EP, Garvan C, Shrivastav R, Sapienza CM. Combined modality treatment of adductor spasmodic dysphonia. J Voice. 2012;26:77–86.

    Article  PubMed  Google Scholar 

  43. Murry T, Woodson GE. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy. J Voice. 1995;9:460–5.

    Article  CAS  PubMed  Google Scholar 

  44. Pitman MJ. Treatment of spasmodic dysphonia with a neuromodulating electrical implant. Laryngoscope. 2014;124:2537–43.

    Article  PubMed  Google Scholar 

  45. Troung DD, Rontal M, Rolnick M, Aronson AE, Mistura K. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope. 1991;101:630–4.

    CAS  PubMed  Google Scholar 

  46. Paniello RC, Barlow J, Serna JS. Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results. Laryngoscope. 2008;118:564–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, University of Gissen, Klinikstrasse 33, Giessen, 35390, Germany

    Claus Wittekindt

Authors
  1. Claus Wittekindt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claus Wittekindt .

Editor information

Editors and Affiliations

  1. Department of Otorhinolaryngology/Head and Neck Surgery, Clinical Centre Stuttgart, Stuttgart, Germany

    Christian Sittel

  2. Department of Otorhinolaryngology and Institute of Phoniatry and Pedaudiology, Jena University Hospital, Jena, Germany

    Orlando Guntinas-Lichius

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wittekindt, C. (2018). Spasmodic Dysphonia (Laryngeal Dystonia). In: Sittel, C., Guntinas-Lichius, O. (eds) Neurolaryngology. Springer, Cham. https://doi.org/10.1007/978-3-319-61724-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61724-4_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61722-0

  • Online ISBN: 978-3-319-61724-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation